Science Explorer Back to mapMap
Discussion
Company · Derio · Spain

Innoprot (Spain)

innoprot.comROR OpenAlex
Research works
12
▼ 69% vs 2018-21
Citations
239
20.8 per fractional work
Top-10% rate
2.5%
all institutions 10.0%
Open access
91%
world 40%
International
39%
world 18%
Innoprot (Spain)

Not ranked overall: Innoprot (Spain) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does Innoprot (Spain) work in?

In all years, 47% of research at Innoprot (Spain) is in Life Sciences, 34% in Health Sciences. Its largest fields are Medicine (34%), Biochemistry, Genetics and Molecular Biology (28%), Chemistry (15%). It does 1.8× the world's share of Life Sciences.

Life Sciences: 5 fractional works · 46.7% of its workBiochemistry, Genetics and Molecular Biology: 3 fractional works · 27.7% of its workMolecular Biology: 3 fractional works · 25.1% of its workCell Biology: 0 fractional works · 1.6% of its workCancer Research: 0 fractional works · 0.6% of its workPhysiology: 0 fractional works · 0.5% of its workNeuroscience: 1 fractional works · 11.1% of its workCellular and Molecular Neuroscience: 1 fractional works · 9.2% of its workDevelopmental Neuroscience: 0 fractional works · 1.0% of its workNeurology: 0 fractional works · 1.0% of its workAgricultural and Biological Sciences: 1 fractional works · 4.9% of its workAnimal Science and Zoology: 0 fractional works · 2.9% of its workFood Science: 0 fractional works · 1.0% of its workPlant Science: 0 fractional works · 1.0% of its workSmaller subfields together: 0 fractional works · 0.1% of its workImmunology and Microbiology: 0 fractional works · 1.6% of its workImmunology: 0 fractional works · 1.1% of its workMicrobiology: 0 fractional works · 0.4% of its workPharmacology, Toxicology and Pharmaceutics: 0 fractional works · 1.4% of its workPharmaceutical Science: 0 fractional works · 1.0% of its workToxicology: 0 fractional works · 0.4% of its workHealth Sciences: 4 fractional works · 34.0% of its workMedicine: 4 fractional works · 34.0% of its workPhysiology: 1 fractional works · 6.7% of its workNeurology: 1 fractional works · 6.2% of its workOncology: 0 fractional works · 4.3% of its workRadiology, Nuclear Medicine and Imaging: 0 fractional works · 4.3% of its workEpidemiology: 0 fractional works · 3.8% of its workImmunology and Allergy: 0 fractional works · 3.0% of its workPharmacology: 0 fractional works · 2.1% of its workGenetics: 0 fractional works · 1.0% of its workInfectious Diseases: 0 fractional works · 1.0% of its workGeriatrics and Gerontology: 0 fractional works · 0.7% of its workOphthalmology: 0 fractional works · 0.5% of its workPublic Health, Environmental and Occupational Health: 0 fractional works · 0.5% of its workPhysical Sciences: 2 fractional works · 19.3% of its workChemistry: 2 fractional works · 15.1% of its workOrganic Chemistry: 1 fractional works · 7.7% of its workInorganic Chemistry: 1 fractional works · 4.5% of its workAnalytical Chemistry: 0 fractional works · 2.9% of its workEngineering: 0 fractional works · 3.3% of its workBiomedical Engineering: 0 fractional works · 3.3% of its workComputer Science: 0 fractional works · 0.9% of its workComputational Theory and Mathematics: 0 fractional works · 0.9% of its workALL ITS WORKInnoprot (Spain)12fractional works, all years
Life Sciences47%Physical Sciences19%Health Sciences34%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 3 domains and 9 fields, with their numbers
    1. Biochemistry, Genetics and Molecular Biology327.7%
    2. Neuroscience111.1%
    3. Agricultural and Biological Sciences14.9%
    4. Immunology and Microbiology01.6%
    5. Pharmacology, Toxicology and Pharmaceutics01.4%
    1. Medicine434.0%
    1. Chemistry215.1%
    2. Engineering03.3%
    3. Computer Science00.9%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 1.96× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 4.04× its world share, 0 worksBiochemistry, Geneti…Immunology and Microbiology: 3.96× its world share, 0 worksImmunology and Micro…Neuroscience: 8.35× its world share, 0 worksNeuroscienceComputer Science: 0.40× its world share, 0 worksComputer ScienceMedicine: 2.53× its world share, 1 worksMedicine1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Neuroscience, 8.3×. Every wedge is a field page.

All 6 fields, with their numbers
  1. Neuroscience8.35×0 works
  2. Biochemistry, Genetics and Molecular Biology4.04×0 works
  3. Immunology and Microbiology3.96×0 works
  4. Medicine2.53×1 works
  5. Agricultural and Biological Sciences1.96×0 works
  6. Computer Science0.40×0 works

Who are the top researchers at Innoprot (Spain)?

Ranked on the quality score, Clarisa Salado, Patricia Villacé and Isbaal Ramos lead among researchers whose main affiliation is Innoprot (Spain).

  1. 1 Clarisa Salado Spain · #2,911,804 worldwide 1.2k citations · 36 works
  2. 2 Patricia Villacé Spain · #3,148,123 worldwide 484 citations · 17 works
  3. 3 Isbaal Ramos Spain · #3,980,149 worldwide 693 citations · 20 works
All ranked researchers at Innoprot (Spain)

What are the most cited papers from Innoprot (Spain)?

The most cited paper from Innoprot (Spain) is "Assessing the role of surface glycans of extracellular vesicles on cellular uptake" (C. B. Williams, Raquel Pazos, Félix Royo et al., 2019), with 179 citations. Next come "Discoidin domain receptor 2 deficiency predisposes hepatic tissue to colon carcinoma metastasis" (76) and "Biological evaluation of morin and its new oxovanadium(IV) complex as antio-xidant and specific anti-cancer agents" (71).

Most cited papers
#PaperReleasedCitations
1 Assessing the role of surface glycans of extracellular vesicles on cellular uptake C. B. Williams, Raquel Pazos, Félix Royo et al. · Scientific Reports Open access 15 Aug 2019 179
2 Discoidin domain receptor 2 deficiency predisposes hepatic tissue to colon carcinoma metastasis Iker Badiola, Elvira Olaso, Olatz Crende et al. · Gut 9 Nov 2011 76
3 Biological evaluation of morin and its new oxovanadium(IV) complex as antio-xidant and specific anti-cancer agents Luciana G. Naso, Luis M. Lezama, Teófilo Rojo et al. · Chemico-Biological Interactions Open access 11 Oct 2013 71
4 Bovine serum albumin binding, antioxidant and anticancer properties of an oxidovanadium(IV) complex with luteolin Luciana G. Naso, Luis M. Lezama, María Valcárcel et al. · Journal of Inorganic Biochemistry Open access 22 Jan 2016 69
5 Solid lipid nanoparticles for delivery of Calendula officinalis extract Lide Arana, Clarisa Salado, Sandra Vega et al. · Colloids and Surfaces B Biointerfaces 17 Jul 2015 67
All 33 most cited papers, with filters and sorting

Which research topics does Innoprot (Spain) publish most on?

By volume in 2022-now: Probiotics and Fermented Foods, Nerve injury and regeneration, Antimicrobial Resistance in Staphylococcus and Microbial Natural Products and Biosynthesis.

Probiotics and Fermented Foods: 0 fractional worksNerve injury and regeneration: 0 fractional worksAntimicrobial Resistance…0Antimicrobial Resistance in Staphylococcus: 0 fractional worksMicrobial Natural Products and Biosynthesis: 0 fractional worksOcular Surface and Contact Lens: 0 fractional worksCorneal Surgery and Treatments: 0 fractional worksPharmacological Receptor Mechanisms and Effects: 0 fractional worksGlaucoma and retinal dis…0Glaucoma and retinal disorders: 0 fractional worksNeuroscience and Neuropharmacology Research: 0 fractional worksBiochemical effects in animals: 0 fractional works
Food ScienceCellular and Molecular NeuroscienceInfectious DiseasesPharmacology5 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Probiotics and Fermented Foods Food Science 0 works
  2. 2 Nerve injury and regeneration Cellular and Molecular Neuroscience 0 works
  3. 3 Antimicrobial Resistance in Staphylococcus Infectious Diseases 0 works
  4. 4 Microbial Natural Products and Biosynthesis Pharmacology 0 works
  5. 5 Ocular Surface and Contact Lens Public Health, Environmental and Occupational Health 0 works
  6. 6 Corneal Surgery and Treatments Radiology, Nuclear Medicine and Imaging 0 works
  7. 7 Pharmacological Receptor Mechanisms and Effects Molecular Biology 0 works
  8. 8 Glaucoma and retinal disorders Ophthalmology 0 works
  9. 9 Neuroscience and Neuropharmacology Research Cellular and Molecular Neuroscience 0 works
  10. 10 Biochemical effects in animals Physiology 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available90.6%not open9.4%

World: 40% of research is openly available.

with international co-authors38.6%domestic only61.4%

World: 18% is written across borders.

How has Innoprot (Spain)'s research output changed?

Output in 2022-2025 was 69% lower than in 2018-2021.

still counting201520202025
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Innoprot (Spain) as a percentage of every work published that year, 0.0000051% in 2024.

still counting0.000025%0.000050%0.000075%Innoprot (Spain)0.0000043% in 20252020

Fractional works of Innoprot (Spain) over all fractional works that year. How the balance of science has shifted.

Other research institutions in Derio

All research institutions in Derio

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Innoprot (Spain). Posts are plain text and can be reported.